549
Views
4
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Evidence that prehypertension is a risk factor for Type 2 diabetes

&
Pages 335-337 | Published online: 10 Jan 2014

References

  • Mullican DR, Lorenzo C, Haffner SM. Is prehypertension a risk factor for the development of Type 2 diabetes? Diabetes Care32(10), 1870–1872 (2009).
  • Chobanian AV, Bakris GL, Black HR et al.; National High Blood Pressure Education Program Coordinating committee. The seventh report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA289, 2560–2572 (2003).
  • Joint National committee. The sixth report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med.157, 2413–2446 (1997).
  • Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch. Intern. Med.153, 598–615 (1993).
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA285, 2486–2497 (2001).
  • Schmidt MI, Duncan BB, Bang H et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care28, 2013–2018 (2005).
  • Mainous AG III, Diaz VA, Everett CJ. Assessing risk for development of diabetes in young adults. Ann. Fam. Med.5, 425–429 (2007).
  • Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing Type 2 diabetes mellitus: the Women’s Health Study. Eur. Heart J.28, 2937–2943 (2007).
  • Qureshi AI, Suri MFK, Kirmani JF et al. Is prehypertension a risk factor for cardiovascular diseases? Stroke36, 1859–1863 (2005).
  • Hsia J, Margolis KL, Eaton CB et al. Prehypertension and cardiovascular disease risk in the Women’s Health Initiative. Circulation115, 855–860 (2007).
  • Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N. Engl. J. Med.345, 1291–1297 (2001).
  • Liszka HA, Mainous AG III, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann. Fam. Med.3, 294–299 (2005).
  • Lorenzo C, Aung K, Stern MP, Haffner SM. Pulse pressure, prehypertension, and mortality: the San Antonio Heart study. Am. J. Hypertens.22, 1219–1226 (2009).
  • Mainous AG III, Everett CJ, Liszka H, King DE, Egan BM. Prehypertension and mortality in a nationally representative cohort. Am. J. Cardiol.94, 1496–1500 (2004).
  • Sequra J, Ruilope LM. Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros? Diabetes Care32(Suppl. 2), S284–S289 (2009).
  • Nilsson PM. Hypertension and diabetes: should we treat early surrogates? What are the cons? Diabetes Care32(Suppl. 2), 290–293 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.